Explicit|||146..149||and||0|and|||Expansion.Conjunction|||||||||||0..145|0|firstly, the patient cohort in open studies and in clinic experience, at the time of rituximab treatment, had moderate to severe disease activity||||||||150..197|0|most had failed conventional immunosuppressants|||||||||||||
Explicit|||272..275||but||1|but|||Comparison.Contrast|||||||||||199..270|1|in contrast patients participating in the two dbrcts had active disease||||||||276..334|1|patients who had failed conventional therapy were excluded|||||||||||||
Explicit|||199..210||in contrast||1|in contrast|||Comparison.Contrast|||||||||||0..197|0|firstly, the patient cohort in open studies and in clinic experience, at the time of rituximab treatment, had moderate to severe disease activity and most had failed conventional immunosuppressants||||||||211..334|1|patients participating in the two dbrcts had active disease, but patients who had failed conventional therapy were excluded|||||||||||||
